| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |